This Could Save Your Life (1 in 4 People Have This Silent Killer Disease)

Berg dismantles mainstream vitamin D guidelines by pointing out that reference ranges (20–30 ng/mL) are based on preventing rickets, not optimizing immunity. He distinguishes between studies using monthly bolus doses (which failed to show benefit) and daily dosing (which is necessary because vitamin D has a short half-life for immune actions). Historical evidence from sanatoriums, where sun exposure and cod liver oil (rich in vitamin D) dramatically improved TB survival, supports this protocol. The protocol is framed as a way to tip the balance in favor of the host when a latent infection is present, rendering the environment inhospitable for TB activation.

Berg highlights that 93% of the population spends most of their time indoors under LED lights that emit only visible light (heavy in blue) with no infrared. He criticizes the upcoming 2028 mandate that will phase out incandescent bulbs (which have some infrared) in favor of even brighter narrow-spectrum LEDs, predicting worsened sleep, elevated cortisol, and greater disease susceptibility. The protocol is a return to the natural design of human biology, congruent with the pre-antibiotic sanatorium model where sun exposure slashed TB mortality from ~70% to 30–40%.

Berg details a multi-step survival strategy: after being engulfed by a macrophage, TB blocks the enzymes and acid intended to kill it. Instead of destroying the host cell, it builds a protective shield around itself within the macrophage and then hijacks the mitochondria’s fuel source to persist in a dormant mode, waiting for immune weakness—especially low vitamin D—to reactivate.

Berg points out that TB has evolved a strategy of blocking the vitamin D receptor, so the more the receptor is blocked, the lower the immune power. This is a survival mechanism because TB 'knows' it needs to reduce host immunity to persist. Consequently, even 'normal' vitamin D levels may not protect an infected person; higher saturation is needed to force signaling through the blocked receptor.

Berg analyzed the discrepant studies and found that those claiming no correlation used monthly vitamin D3 doses, which fail to maintain consistent blood levels. He stresses that daily dosing at 6,000–10,000 IU (or even higher for therapeutic purposes) is necessary, not the outdated 600–800 IU RDA. The argument is that monthly doses don't provide the sustained immune activation needed, especially when TB is blocking vitamin D receptors.

Berg explains that over 50% of sunlight is infrared (invisible heat). This wavelength penetrates tissues and reverses the mitochondrial damage TB causes in macrophages—specifically, it increases oxygen and nitric oxide within the mitochondria, both of which are weapons against TB. He ties this to broader infrared therapy uses for chronic fatigue, sleep cycles, and melatonin production, emphasizing that our bodies are designed to receive full-spectrum sun, not just visible light from LEDs.

Berg notes that in the 1980s, sun-phobia campaigns warning about skin cancer and promoting sunscreen coincided with a measurable increase in TB outbreaks. He argues that reduced sun exposure drastically cut vitamin D levels in the population, removing the primary immune barrier that keeps latent TB dormant. This connection underscores the idea that TB reactivation is largely an environmental and epigenetic problem, not just a pathogen-driven one.